LataMed AI Corp. partners with Venezuelan pharmacies to deploy AI-powered prescription processing and fulfillment platform, aiming to modernize healthcare logisticsLataMed AI Corp. partners with Venezuelan pharmacies to deploy AI-powered prescription processing and fulfillment platform, aiming to modernize healthcare logistics

LataMed AI Partners With Venezuelan Pharmacies for AI-Powered Prescription Fulfillment

2026/05/26 20:53
3 min read
For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

LataMed AI Corp. (OTC: LMED), a development-stage digital health and artificial intelligence technology company, announced that it has reached commercial terms with two leading pharmacy retail operators in Caracas, Venezuela, to deploy its AI-powered prescription processing and pharmaceutical fulfillment platform. The initiative is a key step in the company’s broader Latin American commercialization strategy and aims to establish an operational framework for its AI-driven healthcare logistics ecosystem.

Venezuela was selected as the initial target market due to increasing interest in technology-enabled healthcare infrastructure and opportunities for modernization within the country’s pharmaceutical distribution sector. Management believes that successful deployment and market evaluation in Venezuela could provide a model for expansion into other South American markets as part of the company’s long-term regional strategy.

The platform is designed to streamline traditional prescription fulfillment workflows through mobile-enabled prescription intake, artificial intelligence-based text recognition, automated inventory verification, fulfillment coordination, and delivery routing technologies. According to the company, the platform addresses operational inefficiencies in underserved healthcare distribution markets across Latin America.

Under the planned deployment, the platform is intended to improve prescription processing efficiency, reduce administrative overhead, optimize pharmacy inventory coordination, and enhance customer accessibility through technology-enabled fulfillment and delivery systems. Management believes the initiative offers several commercial advantages, including initial entry into an active pharmaceutical retail environment in a major Latin American metropolitan market, real-world evaluation opportunities for the platform, potential recurring transaction-based revenue from prescription fulfillment volumes, and a scalable framework for future regional expansion.

The pharmacy fulfillment initiative is intended to integrate with LataMed’s broader digital healthcare ecosystem, which includes telehealth applications, healthcare analytics infrastructure, patient engagement technologies, and AI-assisted healthcare coordination platforms currently under development. Management believes that integrating pharmacy fulfillment capabilities will enhance operational scalability, improve user accessibility, support future platform interoperability, and strengthen the company’s long-term digital healthcare commercialization strategy throughout Latin America.

Dr. Kevin Rodan Levy, Chief Executive Officer of LataMed AI Corp., stated: ‘We believe pharmacy fulfillment represents a natural extension of our digital healthcare infrastructure strategy. By combining AI-enabled prescription processing, logistics coordination, and pharmacy retail participation, we are continuing development of healthcare technology solutions designed to support accessibility, operational efficiency, and scalability across Latin America.’

The company emphasized that the platform and related deployment activities remain subject to continued operational planning, technology integration, commercial readiness, regulatory considerations, partner implementation timelines, financing availability, and market adoption. No assurance can be provided regarding the timing of broader commercial deployment, transaction volumes, revenue generation, geographic expansion, or operational success.

LataMed continues to advance telehealth deployment initiatives, healthcare analytics integration, operational scalability planning, strategic relationship development, and broader commercialization efforts associated with its long-term digital healthcare ecosystem strategy throughout Latin America and other emerging markets.

For more information, visit LataMed AI’s website or review the company’s filings with the U.S. Securities and Exchange Commission at www.sec.gov.

Blockchain Registration, Verification & Enhancement provided by NewsRamp™

This news story relied on content distributed by NewMediaWire. Blockchain Registration, Verification & Enhancement provided by NewsRamp™. The source URL for this press release is LataMed AI Partners With Venezuelan Pharmacies for AI-Powered Prescription Fulfillment.

The post LataMed AI Partners With Venezuelan Pharmacies for AI-Powered Prescription Fulfillment appeared first on citybuzz.

Market Opportunity
Gensyn Logo
Gensyn Price(AI)
$0.03
$0.03$0.03
+0.60%
USD
Gensyn (AI) Live Price Chart

AI Strategy: Powered 24/7

AI Strategy: Powered 24/7AI Strategy: Powered 24/7

Generate automated strategies using natural language

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

No Chart Skills? Still Profit

No Chart Skills? Still ProfitNo Chart Skills? Still Profit

Copy top traders in 3s with auto trading!